Chantel Collier, NP
Family · Friend, NENPI 1285158428
Payments from drug & device makers
What this record shows
This record is dominated by other: $256,600 of the $257,386 with a category attached, or 99.7%. Convatec Inc. accounts for 99.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $256,818, more than ten times the $14 reported in 2021. Among family clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $5252.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$257K
- Johnson & Johnson$132
- AbbVie$62
- Biowound Solutions, Inc.$40
- Otsuka America Pharmaceutical, Inc.$37
- Axsome Therapeutics, Inc.$19
- plus $27 from 2 others
What the payments were for
- Food & beverage$7860%
- Other$256,600100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 39 | $257,070 |
| Johnson & Johnson | 1 | $132 |
| AbbVie | 2 | $62 |
| Biowound Solutions, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$256,909
- SPRAVATO$132
How this compares
$257,386 in reported general payments places this provider in the 95th percentile of 809 family providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 22 | $49,654 |
| OzempicSemaglutide | 21 | $21,135 |
| JardianceEmpagliflozin | 22 | $13,172 |
| Ventolin HfaAlbuterol Sulfate | 11 | $838 |
| Fluconazole | 11 | $479 |
| Bupropion XlBupropion Hcl | 36 | $459 |
| Gabapentin | 15 | $453 |
| Fenofibrate | 12 | $353 |
| Memantine Hcl | 12 | $295 |
| Montelukast Sodium | 19 | $200 |
| Omeprazole | 31 | $172 |
| Metformin Hcl ErMetformin Hcl | 20 | $171 |
| Diazepam | 19 | $168 |
| Metoprolol Succinate | 20 | $150 |
| Cyclobenzaprine Hcl | 15 | $144 |
Paid to pharmacies, not to this prescriber.
Other family in Friend
- Stephanie SimonOmaha$157K
- Rebecca NewberryOmaha$156K
- Michelle BrtekzwienerNorfolk$59K
- Angela CraigOmaha$35K
- Laura FalconeOmaha$26K
- Ladeana SmedlundBoys Town$21K
- Brittany MatneyOmaha$14K
- Patricia TeeterWahoo$13K
- Mary MetzLincoln$13K
- Sara LegleiterOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.